Healthcare

Dba steps up its efforts in the healthcare sector: work is underway on the design of the Varese Cancer Day Hospital

A total investment of €4.39 million to refurbish around 1,800 square metres of the hospital complex. The group is reorganising its brands and focusing on its strategic plan for 2030

Il render del progetto di Varese

5' min read

Translated by AI
Versione italiana

5' min read

Translated by AI
Versione italiana

It is also at the hospital in Varese that one of the key elements of the Dba Group’s growth strategy in the healthcare sector is taking shape. The Villorba-based group, listed on Euronext Growth Milan and active in technical consultancy, engineering, project management and ICT solutions for infrastructure and mission-critical projects, has, through its Dba General Planning brand, been awarded the contract to design the new Oncology Day Hospital and the facilities for Metabolic Radiotherapy at the ASST Sette Laghi – Ospedale di Circolo and Fondazione Macchi in Varese.

A project costing over 4 million

The project forms part of a wider property redevelopment scheme with a total value of approximately 4.39 million euros and involves the relocation of the Oncology Day Hospital to the new hospital complex. Approximately 1,800 square metres are earmarked for the Oncology Day Hospital (DHO) and the Anti-Blast Chemo-Therapy Handling Unit (UMACA), in addition to the construction of a new Metabolic Radiotherapy Department, complete with specialised equipment and radiation protection systems. Dba will be responsible for the technical and economic feasibility study and the detailed design. The design work must be completed within 120 days, whilst the overall construction programme is scheduled to take approximately 31 months.

Loading...

For the group, this is not just another new contract, but a project that forms part of a body of expertise built up over the years in the healthcare sector and, in particular, in oncology. “This project at Varese Hospital builds on a series of designs and projects we have already carried out,” explains Daniele De Bettin, CEO of Dba. “It focuses on the field of oncology, where we have already worked for the IEO in Milan.” This refers to the Proton Centre built for the European Institute of Oncology, which opened in 2023, a highly specialised facility for proton therapy.

Project details

In Varese, on the other hand, the scale of the project is more modest, but the technical complexity remains high. “It isn’t a large-scale project, but it’s very interesting because it involves refurbishing part of the Fondazione Macchi hospital,” explains the manager. The project covers the areas for the administration of cancer treatments, metabolic radiotherapy and the Umaca unit. The aim, adds De Bettin, is twofold: “We are going to improve the quality of services at the Varese hospital and, furthermore, it allows us to build on our expertise and maintain our presence in this market segment.”

Strategy for the healthcare sector

Healthcare is, in fact, one of the sectors on which Dba intends to base part of its growth. “The healthcare sector represents one of our strategic areas of development, and this new contract confirms our ability to support healthcare facilities through their transformation processes,” emphasises De Bettin. The group’s positioning extends beyond design alone. The growing complexity of hospitals requires the integration of spaces, systems, medical technologies and operational workflows. This evolution is also evident in the increasing use of robotics in operating theatres.

“There will be more and more of these innovative technologies in hospitals,” observes De Bettin. Dba does not manufacture the robots itself, but designs the spaces to accommodate them: “This has an impact on the layout and construction techniques, which must take into account additional weights and, naturally, different systems compared to the past, to enable these robots to operate.” This issue is indicative of a market in which the engineering of healthcare spaces must keep pace with clinical and technological innovation.

The reorganisation of the brands

The Varese contract comes at a time when the group is in the process of completing an internal reorganisation. Dba has, in fact, been working on restructuring its brands, with the aim of making the group’s structure clearer and, at the same time, highlighting the expertise and identity gained through acquisitions. One of the key priorities is the strengthening of General Planning, a company acquired a year ago with a history stretching back over fifty years. Within the building sector, General Planning operates across several key areas: industrial, life sciences, healthcare and real estate. Among the most dynamic segments is that of data centres, a market which has seen strong growth over the last four to five years, including in Italia. This activity is complemented by the industrial manufacturing and food & beverage sectors – including a collaboration with Nestlé on the Purina plant project in Mantua – and, above all, the pharmaceutical and life sciences sectors. “There is a great deal to be done in the pharmaceutical sector,” observes De Bettin, pointing to another market in which the group sees scope for growth. In the property sector, however, one of the most interesting areas is the hotel industry, which is also being driven by the transformation of Italia’s hotel portfolio. The fragmentation of the sector and the generational transition are facilitating the entry and expansion of major international chains.

However, the reorganisation does not concern General Planning alone. It is a group-wide initiative that takes into account the acquisitions made in recent years. The platform now brings together a range of companies and areas of expertise: from Dba Sjs Engineering, based in Rome and specialising in the port and maritime sectors, to Dba General Planning, which focuses on the property market, and the Spanish firm Dba Ifg Proyectos.

Towards the 2030 Strategic Plan

The reorganisation of the brands marks a new phase of development for the Dba Group. 2026 will see the conclusion of the first strategic plan launched following the group’s stock market listing, and the group is already working towards its new 2030 vision, which will set out its future growth strategies. The strategy will continue to combine organic growth, partnerships and targeted acquisitions. “We do not make acquisitions simply for the sake of taking over other companies: we aim to strengthen our position in specific segments,” explains De Bettin. The aim is to progressively increase the group’s scale and competitive strength.

This trajectory is reflected in the results. In 2025, Dba Group recorded a production value of €129.8 million, up from €115.8 million in 2024, whilst adjusted EBITDA rose to €14 million, compared with €12.5 million in the previous financial year. Profit growth was even more pronounced: net profit rose from 3.4 to 5.5 million, whilst group profit rose from 3 to 4.9 million. On the financial front, the net debt position fell from 9.2 to 3.8 million. The group has also proposed a dividend of 0.14 euros per share, compared with 0.13 euros in 2024. For 2026, the budget forecasts a production value of between 134 and 138 million, an EBITDA of between 14.5 and 15 million, and a net debt position of between 2 and 3 million.

Copyright reserved ©
Loading...
Loading...

Brand connect

Loading...

Newsletter RealEstate+

La newsletter premium dedicata al mondo del mercato immobiliare con inchieste esclusive, notizie, analisi ed approfondimenti

Abbonati